Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis

被引：0
|
作者：
Franklin, Gillian [1 ]
Greenspan, Joel [2 ]
Chen, Sheng [1 ]
机构：
[1] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Pathol, New Hyde Pk, NY 11040 USA
[2] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Med, New Hyde Pk, NY 11040 USA
来源：
ANNALS OF CLINICAL AND LABORATORY SCIENCE | 2009年 / 39卷 / 02期
关键词：
anti-TNF-alpha monoclonal antibody; adalimumab; leishmaniasis; rheumatoid arthritis; SERIOUS BACTERIAL-INFECTIONS; VISCERAL LEISHMANIASIS; TNF-ALPHA; INFLIXIMAB; ANTAGONISTS; RISK;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
It has been reported that anti-tumor necrosis factor-alpha therapy increases the risk of opportunistic infections including rare case reports of leishmaniasis. Here we report a case of latent cutaneous leishmaniasis, which was provoked by anti-tumor necrosis factor-alpha therapy in a patient with rheumatoid arthritis.
引用
收藏
页码：192 / 195
页数：4
相关论文
共 50 条
  • [21] Risk of Serious Infection and Malignancy in Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Biologics
    Thyagarajan, Veena
    Norman, Heather
    Enger, Cheryl
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 160 - 160
  • [22] Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
    Daniel, Rodney S.
    Bourne, Rae L.
    Simpson, Annie N.
    O'Rourke, Kenneth S.
    Bolster, Marcy B.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2009, 1 (02) : 81 - 89
  • [23] Pulmonary cryptococcosis after initiation of anti-Tumor Necrosis Factor-alpha therapy
    Hage, CA
    Wood, KL
    Sarosi, G
    Knox, KS
    [J]. CHEST, 2003, 124 (04) : 254S - 255S
  • [24] Leishmaniasis in otorhinolaryngology: an emerging disease and its relationship with anti-tumor necrosis factor-alpha drugs
    Penella, Anna
    Muntaner-Virgili, Clara
    Marcoval, Joaquim
    Gonzalez-Compta, Xavier
    Mesalles-Ruiz, Marta
    Wagner, Miguel Garcia
    Cruellas, Francesc
    Hamdan, Miriam
    Nogues, Julio
    Notario, Jaime
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (05) : 2739 - 2742
  • [25] Leishmaniasis in otorhinolaryngology: an emerging disease and its relationship with anti-tumor necrosis factor-alpha drugs
    Anna Penella
    Clara Muntaner-Virgili
    Joaquim Marcoval
    Xavier González-Compta
    Marta Mesalles-Ruiz
    Miguel García Wagner
    Francesc Cruellas
    Miriam Hamdan
    Julio Nogués
    Jaime Notario
    [J]. European Archives of Oto-Rhino-Laryngology, 2024, 281 : 2739 - 2742
  • [26] Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis
    Semerano, Luca
    Assier, Eric
    Delavallee, Laure
    Boissier, Marie-Christophe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (04) : 545 - 550
  • [27] ORAL GLUCOCORTICOID USE IN RITUXIMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH PRIOR EXPOSURE TO ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY
    Johnston, S. S.
    Kamath, T.
    Shi, N.
    Fowler, R.
    Chu, B. C.
    Reiss, W.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A218 - A218
  • [28] Prophylactic Therapy for Latent Tuberculosis Prior to Anti-Tumor Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: A Decision Analysis
    Hazlewood, Glen S.
    Naimark, David
    Gardam, Michael
    Bykerk, Vivian
    Bombardier, Claire
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S41 - S42
  • [29] Prophylactic Therapy for Latent Tuberculosis Prior to Anti-Tumor Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: A Decision Analysis
    Hazlewood, Glen
    Naimark, David
    Gardam, Michael
    Bykerk, Vivian
    Bombardier, Claire
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1730 - 1730
  • [30] Anti-Tumor Necrosis Factor Alpha Therapy and Periodontal Inflammation in Rheumatoid Arthritis A clinical and biochemical approach
    Ancuta, Codrina
    Ancuta, Eugen
    Chirieac, Rodica
    Antohe, Magda
    Iordache, Cristina
    [J]. REVISTA DE CHIMIE, 2017, 68 (02): : 369 - 372
12345